Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Major Depressive Disorder, Single Episode, Severe With Psychotic Features”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Testing effectiveness (Phase 2)Study completedNCT00844922
What this trial is testing

Safety of Org 34517 900 mg in Patients Who Received Org 34517 in a Previous Trial (Study 28133/P05842)

Who this might be right for
Depressive DisordersPsychotic DisordersDepression
Merck Sharp & Dohme LLC 16
Testing effectiveness (Phase 2)Study completedNCT01731119
What this trial is testing

Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+10 more
University of North Carolina, Chapel Hill 9
Not applicableStudy completedNCT04874974
What this trial is testing

Feasibility of a Novel Process-based Treatment for Patients With Psychosis

Who this might be right for
SchizophreniaSchizotypal DisorderDelusional Disorder+10 more
Max-Planck-Institute of Psychiatry 37
Testing effectiveness (Phase 2)Study completedNCT00212797
What this trial is testing

Determine the Efficacy and Safety of 2 Doses of Org 34517 as Adjunctive Therapy in Subjects With Psychotic Major Depression (28130)(P05845)

Who this might be right for
DepressionDepressive DisordersPsychotic Disorders
Merck Sharp & Dohme LLC 273